Therapeutic potential of S-nitrosothiols as nitric oxide donor drugs.
Megson
I L
IL
Clinical Pharmacology Unit & Research Centre, University of Edinburgh, Western General Hospital. IM@srv0.med.ed.ac.uk
Greig
I R
IR
Butler
A R
AR
Gray
G A
GA
Webb
D J
DJ
D000818:Animals; D005944:Glucosamine / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D009569:Nitric Oxide / Q000378:metabolism*; D009603:Nitroso Compounds / Q000494:pharmacology / Q000627:therapeutic use*; D010396:Penicillamine / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D051381:Rats; D026423:S-Nitroso-N-Acetylpenicillamine; D014665:Vasodilator Agents / Q000494:pharmacology / Q000627:therapeutic use*
D009603:Nitroso Compounds; C109931:RIG 200; D014665:Vasodilator Agents; D009569:Nitric Oxide; D026423:S-Nitroso-N-Acetylpenicillamine; D010396:Penicillamine; D005944:Glucosamine